Polyradiculoneuropathy, Chronic Inflammatory Demyelinating [clinicaltrials_resource:407b4e57980817a6717af8026620d172]
Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy [clinicaltrials:NCT00004286]Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy [clinicaltrials:NCT00004772]Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy [clinicaltrials:NCT00004939]Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [clinicaltrials:NCT00220740]Study of CIDP Patients During IVIG Treatment [clinicaltrials:NCT00305266]Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) [clinicaltrials:NCT01017159]Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [clinicaltrials:NCT02027701]clinicaltrials:NCT02271724
condition [clinicaltrials_vocabulary:condition]
Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [clinicaltrials:NCT00001287]Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy [clinicaltrials:NCT00004286]Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy [clinicaltrials:NCT00004772]Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy [clinicaltrials:NCT00004939]Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) [clinicaltrials:NCT00099489]Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [clinicaltrials:NCT00220740]Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy [clinicaltrials:NCT00278629]Study of CIDP Patients During IVIG Treatment [clinicaltrials:NCT00305266]Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy [clinicaltrials:NCT00962429]Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) [clinicaltrials:NCT01017159]clinicaltrials:NCT01184846Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDP [clinicaltrials:NCT01225276]High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy [clinicaltrials:NCT01236456]clinicaltrials:NCT01349270Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy [clinicaltrials:NCT01379833]Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20) [clinicaltrials:NCT01545076]clinicaltrials:NCT01625182clinicaltrials:NCT01757574Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy. [clinicaltrials:NCT01824251]clinicaltrials:NCT01847937MRI and Ultrasound Imaging in Diagnosing and Monitoring CIDP and MMN [clinicaltrials:NCT02017769]Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [clinicaltrials:NCT02027701]Immunoglobulin Dosage and Administration Form in CIDP and MMN [clinicaltrials:NCT02111590]Effect of Resistance and Aerobic Exercise in CIDP or MMN [clinicaltrials:NCT02121678]clinicaltrials:NCT02271724Efficacy and Safety Study of I10E in Treatment of Patients With CIDP [clinicaltrials:NCT02293460]Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302 [clinicaltrials:NCT02317562]clinicaltrials:NCT02372149Transcriptome Analysis of the Peripheral Blood in CIDP [clinicaltrials:NCT02404298]clinicaltrials:NCT02414490clinicaltrials:NCT02465359
condition browse [clinicaltrials_vocabulary:condition-browse]
Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [clinicaltrials:NCT00001287]Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy [clinicaltrials:NCT00004286]Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy [clinicaltrials:NCT00004772]Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy [clinicaltrials:NCT00004939]Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) [clinicaltrials:NCT00099489]Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [clinicaltrials:NCT00220740]Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy [clinicaltrials:NCT00278629]Study of CIDP Patients During IVIG Treatment [clinicaltrials:NCT00305266]Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy [clinicaltrials:NCT00962429]Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) [clinicaltrials:NCT01017159]clinicaltrials:NCT01184846Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDP [clinicaltrials:NCT01225276]High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy [clinicaltrials:NCT01236456]clinicaltrials:NCT01349270Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy [clinicaltrials:NCT01379833]Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20) [clinicaltrials:NCT01545076]clinicaltrials:NCT01625182clinicaltrials:NCT01757574Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy. [clinicaltrials:NCT01824251]clinicaltrials:NCT01847937MRI and Ultrasound Imaging in Diagnosing and Monitoring CIDP and MMN [clinicaltrials:NCT02017769]Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [clinicaltrials:NCT02027701]Immunoglobulin Dosage and Administration Form in CIDP and MMN [clinicaltrials:NCT02111590]Effect of Resistance and Aerobic Exercise in CIDP or MMN [clinicaltrials:NCT02121678]clinicaltrials:NCT02271724Efficacy and Safety Study of I10E in Treatment of Patients With CIDP [clinicaltrials:NCT02293460]Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302 [clinicaltrials:NCT02317562]clinicaltrials:NCT02372149Transcriptome Analysis of the Peripheral Blood in CIDP [clinicaltrials:NCT02404298]clinicaltrials:NCT02414490clinicaltrials:NCT02465359
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating [clinicaltrials_resource:407b4e57980817a6717af8026620d172]
Bio2RDF identifier
407b4e57980817a6717af8026620d172
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:407b4e57980817a6717af8026620d172
identifier
clinicaltrials_resource:407b4e57980817a6717af8026620d172
title
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
@en
type
label
Polyradiculoneuropathy, Chroni ...... b4e57980817a6717af8026620d172]
@en
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating